Pfizer Ventures
Cartography Biosciences Closes $67 Million Series B Round Led by Pfizer to Advance CRC T-cell Engager
Cartography Biosciences; Series B Funding; Pfizer Ventures; CBI-1214; T-cell engager; colorectal cancer (CRC); ATLAS platform; SUMMIT platform; antibody therapeutics; oncology